NASDAQ Companies

expects at least $34 million in adjusted EBITDA profitable revenue in 2025 Scottsdale, Ariz., March 27, 2025 (GLOBE NEWSWIRE) — […]

ENCINO, Calif., March 27, 2025 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global leader in delivering state-of-the-art solutions […]

ANDOVER, Mass., March 27, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense […]

Hong Kong, March 27, 2025 (GLOBE NEWSWIRE) — VS Media (Nasdaq: VSME), a leader in creator-driven commerce, announces it has […]

WARRENVILLE, Ill., March 27, 2025 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes […]

HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued […]

-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- […]

Company Outlines Strong Momentum in Margins, Revenue, and Business Growth Entering 2025 West Seneca, New York, March 27, 2025 (GLOBE […]

Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated development of NPM-139, Company’s once […]

Dosing commenced in FORTIFI-HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Updated data from ongoing […]